Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP271022.RAds18iRSsL86gGOU-40nyxVIsYuda7KKp03uVIUhXCts130_assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP271022.RAds18iRSsL86gGOU-40nyxVIsYuda7KKp03uVIUhXCts130_provenance.
• NP917051.RAiCk1c-5a-z5QzuyzOVqtjTc8hflwM_dAv1ZL3Sehc6o130_assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917051.RAiCk1c-5a-z5QzuyzOVqtjTc8hflwM_dAv1ZL3Sehc6o130_provenance.
• NP449518.RApDuqWZHtSEyAdT2FH68YcYDrH3yXofOm4KV2bkvM9-w130_assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP449518.RApDuqWZHtSEyAdT2FH68YcYDrH3yXofOm4KV2bkvM9-w130_provenance.
• NP647646.RAH7Sv6saUUIn0665q5OQsp9hwGvK4L8NQFYkGa59_WSg130_assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP647646.RAH7Sv6saUUIn0665q5OQsp9hwGvK4L8NQFYkGa59_WSg130_provenance.
• NP700836.RADABBsZFMYnqqkIttmr4OI6P3BIjPfIFvPe86sodiLtQ130_assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700836.RADABBsZFMYnqqkIttmr4OI6P3BIjPfIFvPe86sodiLtQ130_provenance.
• NP615550.RARsQgA0JkP_pi__XSo-tQQDpafFOJBXEUKULYzR-lTw8130_assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615550.RARsQgA0JkP_pi__XSo-tQQDpafFOJBXEUKULYzR-lTw8130_provenance.
• assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP700837.RAen-RveYaMtaObXM3NhUN4Cn9xIJt6w2uk0nanw-PTjQ130_assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700837.RAen-RveYaMtaObXM3NhUN4Cn9xIJt6w2uk0nanw-PTjQ130_provenance.
• assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP700840.RAI4xdkWukdOFFVkfVdcmsVZKsIV8HF3rAnVDqknz7Ki4130_assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700840.RAI4xdkWukdOFFVkfVdcmsVZKsIV8HF3rAnVDqknz7Ki4130_provenance.
• NP700842.RAGUFC6JRwF2-8zGcU2AZ8wp2wT4-VTsuE2a_-sagw_SI130_assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700842.RAGUFC6JRwF2-8zGcU2AZ8wp2wT4-VTsuE2a_-sagw_SI130_provenance.
• NP700839.RAmNR4wdWp3We9175ZKxX5eMCPqd7s5sMUQxiJn-6MH-U130_assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700839.RAmNR4wdWp3We9175ZKxX5eMCPqd7s5sMUQxiJn-6MH-U130_provenance.
• NP390102.RAupUlwlybR9IEICOCpE1-HHglRoitwY9mjUCZqqgK2b0130_assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390102.RAupUlwlybR9IEICOCpE1-HHglRoitwY9mjUCZqqgK2b0130_provenance.
• NP615371.RAkJWu9L7yJfzrNdU4qDFn_lOjczjNOW4Xav35JmQuHZc130_assertion description "[Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615371.RAkJWu9L7yJfzrNdU4qDFn_lOjczjNOW4Xav35JmQuHZc130_provenance.